SARENA FRANCIS WILLARD (Chief Strategy Officer) reported 1 transaction at FIVE PRIME THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 3/2/2021ACC: 0001209191-21-015614
Officer· Chief Strategy Officer
Since Sep 2018
-1.16K
Net shares
Net seller
$25.7K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.16K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.16K
Price / share
$22.23
Trade value
$25.74K
% of position
0.9%
2/26/2021
124.59K→123.43K
Total
Net shares
−1.16K
Net value
-$25.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/26/2021 | F · Tax Withholding | −1.16K | $22.23 | $25.74K | 0.9% | 124.59K | 123.43K |
| Total | −1.16K | -$25.74K | ||||||
Derivative Transactions0
No derivative transactions reported